Regal Partners Limited (ASX:RPL) Reports $18.0bn FUM in December 2024
Regal Partners Limited (ASX:RPL) announces $18.0 billion in Funds Under Management for December 2024, showcasing significant annual growth.
Tag: Corporate Strategy & Guidance
Zeus Resources Ltd (ASX:ZEU) Completes Placement of Shortfall
Zeus Resources Ltd announces the placement of its Priority Options shortfall, raising a total of $198,169.
Latin Resources Limited (ASX:LRS) Receives Court Approval for Acquisition
Latin Resources Limited (ASX:LRS) announces court approval for its acquisition by Pilbara Minerals, outlining key dates for shareholders.
KGL Resources Limited (ASX:KGL) Announces CEO Resignation
KGL Resources Limited announces CEO Phillip Condon’s resignation and interim leadership while focusing on the Jervois Copper Project updates.
Global Health Limited (ASX: GLH) Reports Strong Cash Flow Growth
Global Health Limited (ASX: GLH) reports significant cash flow growth and revenue increases for December 2024 quarter amidst challenging market conditions.
Buru Energy Limited (ASX:BRU) Reports Strong Quarterly Progress
Buru Energy Limited (ASX:BRU) reports significant progress in its quarterly report with a focus on the Rafael Project and financial improvements.
Centrex Limited (ASX:CXM) Updates on Entitlement Offer and Expansion Plan
Centrex Limited has launched an Entitlement Offer to raise funds for its Stage 1.5 Expansion, aiming for increased phosphate production capacity.
Murray Cod Australia Limited (ASX:MCA) Announces Security Consolidation
Murray Cod Australia Limited (ASX:MCA) announces a security consolidation reducing holdings by ten times, with key dates outlined.
Charter Hall Wholesale Management Limited (ASX:HPI) Issues Fifth Supplementary Bidder’s Statement
Charter Hall issues a supplementary bidder’s statement urging HPI securityholders to accept its all-cash takeover offer.
Recce Pharmaceuticals (ASX:RCE) Achieves Phase II Trial Milestone
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.